Featured Research

from universities, journals, and other organizations

Killer Peptide May Offer New Therapy Against Influenza A Virus

Date:
December 27, 2008
Source:
American Society for Microbiology
Summary:
In a new study researchers identified what appears to be the first antibody-derived peptide that inhibits the activities of harmful microbes such as influenza A virus and HIV-1.

In a new study researchers identified what appears to be the first antibody-derived peptide that inhibits the activities of harmful microbes such as influenza A virus and HIV-1.

Influenza A viruses continue to result in hospitalization and death, especially among infants, the elderly, and immunocompromised patients worlwide. The emergence of avian influenza A virus and its ability to transfer to humans has brought about new concerns of a pandemic outbreak. Although vaccination can be an effective strategy for preventing influenza, researchers are also placing great emphasis on the discovery and development of antiviral drugs.

A killer decapeptide (KP) represents the internal image of a yeast (Pichia anomala) killer toxin that has an antimicrobial effect against pathogenic organisms. In the study activities of a KP against influenza A virus were evaluated and results showed that KP demonstrated a significant inhibitory effect on the replication of two strains of influenza A virus. Further, mice infected with influenza virus A were inoculated with KP once a day for ten days resulting in an improved survival rate of 40% and significantly decreased viral levels in their lungs.

"Overall, KP appears to be the first anti-idiotypic antibody-derived peptide that displays inhibitory activity and that has a potential therapeutic effect against pathogenic microorganisms, HIV-1, and influenza A virus by different mechanisms of action," say the researchers.


Story Source:

The above story is based on materials provided by American Society for Microbiology. Note: Materials may be edited for content and length.


Journal Reference:

  1. G. Conti, W. Magliani, S. Conti, L. Nencioni, R. Sgarbanti, A.T. Palamara, L. Polonelli. Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection. Antimicrobial Agents and Chemotherapy, 52. 12: 4331-4337

Cite This Page:

American Society for Microbiology. "Killer Peptide May Offer New Therapy Against Influenza A Virus." ScienceDaily. ScienceDaily, 27 December 2008. <www.sciencedaily.com/releases/2008/12/081219093652.htm>.
American Society for Microbiology. (2008, December 27). Killer Peptide May Offer New Therapy Against Influenza A Virus. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2008/12/081219093652.htm
American Society for Microbiology. "Killer Peptide May Offer New Therapy Against Influenza A Virus." ScienceDaily. www.sciencedaily.com/releases/2008/12/081219093652.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins